Patent ID: 6197772
Filing Date: 2001-03-06
Classification: A61P,C07D,Y02P

Abstract:
A compound selected from the group consisting of:4-[1-[3,5bis(trifluoromethyl) benzoyl]-2-(phenylmethy)-4-piperidinyl]-N-(2,6dimethylpheny)-1-piperazine acetamide;4-[1-[3,5bis(trifluoromethyl) benzoyl]-2-(phenylmethy)-4-piperidinyl]-N-(1-phenylcyclohexyl)-1-piperazin e acetamide;1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(1-ph enylcyclohexyl)-1-piperazine acetamide;1-[3,5-bis(trifluoromethyl)benzoyl]-4-[4-[1-[(2-methyl-5-oxazolyl)methyl]-1 H-benzimidazol-2-yl]-1-piperazinyl]-2-(phenylmethyl)piperidine;4-[3,5-bis(trifluoromethyl)benzoyl]-2-[(4-trifluoromethylphenyl)methyl]-4-p iperidinyl]-N-(2,6- dimethylphenyl)-1-piperazine acetamide; and4-[3,5-bis(trifluoromethyl)benzoyl]-2-[(3,4-dichlorophenyl)methyl]-4-piperi dinyl]-N-(2,6-dimethylphenyl)-1-piperazine acetamide;or a N-oxide form, a pharmaceutically acceptable addition salt or a stereochemically isomeric form thereof.